Montag & Associates’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$58.1K Hold
660
﹤0.01% 556
2025
Q1
$60.1K Hold
660
﹤0.01% 576
2024
Q4
$56.9K Hold
660
﹤0.01% 586
2024
Q3
$62.7K Hold
660
﹤0.01% 566
2024
Q2
$60.4K Hold
660
﹤0.01% 558
2024
Q1
$59.9K Hold
660
﹤0.01% 553
2023
Q4
$53.7K Hold
660
﹤0.01% 567
2023
Q3
$52.7K Sell
660
-720
-52% -$57.5K ﹤0.01% 542
2023
Q2
$109K Hold
1,380
0.01% 461
2023
Q1
$107K Hold
1,380
0.01% 454
2022
Q4
$107K Hold
1,380
0.01% 440
2022
Q3
$93K Hold
1,380
0.01% 445
2022
Q2
$106K Hold
1,380
0.01% 430
2022
Q1
$110K Hold
1,380
0.01% 454
2021
Q4
$106K Hold
1,380
0.01% 468
2021
Q3
$100K Hold
1,380
0.01% 472
2021
Q2
$101K Hold
1,380
0.01% 469
2021
Q1
$95K Hold
1,380
0.01% 476
2020
Q4
$92K Buy
+1,380
New +$92K 0.01% 462
2016
Q3
Sell
-3,480
Closed -$204K 250
2016
Q2
$204K Hold
3,480
0.03% 232
2016
Q1
$200K Sell
3,480
-5,290
-60% -$304K 0.03% 226
2015
Q4
$573K Hold
8,770
0.08% 157
2015
Q3
$552K Hold
8,770
0.09% 157
2015
Q2
$620K Hold
8,770
0.09% 167
2015
Q1
$616K Sell
8,770
-11,650
-57% -$818K 0.09% 172
2014
Q4
$1.31M Buy
20,420
+1,200
+6% +$77.1K 0.2% 124
2014
Q3
$1.22M Sell
19,220
-5,890
-23% -$374K 0.2% 124
2014
Q2
$1.56M Sell
25,110
-25,260
-50% -$1.57M 0.25% 111
2014
Q1
$2.94M Buy
50,370
+1,000
+2% +$58.4K 0.5% 71
2013
Q4
$2.62M Sell
49,370
-170
-0.3% -$9.03K 0.45% 75
2013
Q3
$2.37M Hold
49,540
0.44% 75
2013
Q2
$2.25M Buy
+49,540
New +$2.25M 0.46% 72